Riskpilot← Back to searchSign inGet full accessFINNMARKSAPOTEKENE AS
ASActiveOrg 982826047Bjørn Wirkolas Vei 15, 9510 AltaRetail sale of pharmaceutical products · NACE 4773Est. 200187 employeeswww.apotek1.no
Revenue 2025
NOK 222,8M
+12% vs 2024
EBITDA margin
2.8%
+35% vs 2024
Equity ratio
0.6%
Financial strength
Net profit 2025
NOK 5,9M
+39% vs 2024
| Revenue | NOK 222,8M | +12% |
| EBITDA | NOK 6,3M | +35% |
| Net profit | NOK 5,9M | +39% |
| Total assets | NOK 56,7M | +5% |
| Equity | NOK 345K | -91% |
| Employees | 87 | — |
Legal name
FINNMARKSAPOTEKENE AS
Org number
982826047
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
12. januar 2001
Share capital
NOK 100 000
Employees
87 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Apotekdrift, handel og det som naturlig hører inn under dette.
Address
Bjørn Wirkolas Vei 15, 9510 Alta
Phone
+4778449610
Email
kontakt@apotek1.no
Website
www.apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 60 380 | 66 730 | 184 990 | 199 272 | 222 796 |
| Staff expenses | −10 488 | −10 281 | −27 158 | −29 702 | −31 102 |
| EBITDA | −44 | −296 | 6 232 | 4 692 | 6 325 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −44 | −296 | 6 232 | 4 692 | 6 325 |
| Net financials | 13 | 2 | 269 | 828 | 1 303 |
| Profit before tax | −31 | −294 | 6 501 | 5 520 | 7 627 |
| Tax | −0 | −59 | 1 436 | 1 231 | 1 686 |
| Net profit | −31 | −235 | 5 065 | 4 289 | 5 941 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 20 664 | 18 613 | 49 983 | 53 841 | 56 671 |
| Equity | 957 | 932 | 3 515 | 3 804 | 345 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 19 707 | 17 681 | 46 469 | 50 037 | 56 326 |
| Total debt | 19 707 | 17 681 | 46 469 | 50 037 | 56 326 |
EBITDA margin
2.8%
This company
15.8%
Market median
-82% vs market
20212025
Equity ratio
0.6%
This company
38.2%
Market median
-98% vs market
20212025
Return on equity
1723.4%
This company
18.4%
Market median
+9266% vs market
20212025
Net profit margin
2.7%
This company
8.1%
Market median
-67% vs market
20212025
Asset turnover
3.93×
This company
1.12×
Market median
+251% vs market
20212025
Debt / equity
163.40×
This company
0.62×
Market median
-26255% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-02-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HH Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
JJ Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2012 – 2021 | |
| Board of Directors | 2012 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dåvøy Invest As
FINNMARKSAPOTEKENE AS Board members of FINNMARKSAPOTEKENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Janik Johansen | Chief Executive Officer | 0 companies |
| Hege Hillestad | Chief Executive Officer | 0 companies |
| Anita Persen | Chairman | 0 companies |
| Paul Tore Nielsen | Board of Directors | 0 companies |
| Inger Johanne Kristensen | Board of Directors | 0 companies |